In humans, although polymorphisms in the Pla2g2a gene affecting sPLA2-IIA levels have been associated with metabolic disorders, such as coronary heart disease and type II diabetes [63–65], no genetic link between Pla2g2a and FTLD or other neurodegenerative diseases has been reported. The gene discussed is PLA2G2A; the disease is metabolic disease.